DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Scott Weiner is participating on a panel at the Greater Philadelphia Alliance for Capital and Technologies IMPACT 2010 Conference in Philadelphia, PA
News | 11. 09. 2010
